GLP-1 receptor activity
Semaglutide acts primarily at the GLP-1 receptor. Your provider can discuss whether it is an appropriate option for your situation.
Explore semaglutide →GLP-1–based medications affect pathways involved in appetite, digestion and blood-sugar regulation. This guide gives you the useful basics—without pretending an article can tell you which treatment is right for you.
Eligibility and treatment decisions belong to a licensed clinician.
Semaglutide and tirzepatide do not have the same receptor activity.
Your complete medical history is part of clinical review.
GLP-1 is short for glucagon-like peptide-1, a hormone involved in several metabolic processes. Medicines that act on the GLP-1 receptor can influence appetite, digestion and blood-sugar regulation.
That does not make every GLP-1–based medication interchangeable. The specific medication, your health history, other medicines you take and your treatment goals all matter.
Semaglutide acts primarily at the GLP-1 receptor. Your provider can discuss whether it is an appropriate option for your situation.
Explore semaglutide →Tirzepatide acts at both GIP and GLP-1 receptors. A licensed provider can help you understand how that distinction fits into a treatment decision.
Explore tirzepatide →GLP-1–based medications can cause gastrointestinal and other side effects. Serious risks are possible. Follow the instructions provided by your clinician and dispensing pharmacy and seek medical attention for severe or concerning symptoms.
Review safety informationFDA does not review compounded drugs for safety, effectiveness or quality before marketing. If a compounded medication is prescribed, ask your provider questions about treatment and pharmacy fulfillment.
Compare Brunch treatment options and complete a medical intake for independent provider review.